Low THC
Vaporized THC (5 mg)
Loading study record…
The purpose of this research is to assess the analgesic and subjective effects of terpenes administered alone and in combination of THC.
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2026-09-08
What this record can show
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
The overall aim of this placebo-controlled study is to examine dose-dependent analgesia, intoxication, abuse liability, and pharmacokinetics of ecologically relevant doses of vaporized myrcene and beta-caryophyllene administered alone or with vaporized THC.
Linked local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Interventions
Vaporized THC (5 mg)
Vaporized THC (15 mg)
Vaporized Myrcene (0.5 mg)
Vaporized Myrcene (12.0 mg)
Vaporized Beta-Caryophyllene (0.5 mg)
Vaporized Beta-Caryophyllene (7.5 mg)
Vaporized Placebo
Eligibility
primary outcomes
Time frame: 7 hours
Pain threshold and pain tolerance assessed using the Cold Pressor Test
Time frame: 7 hours
Subject ratings of "Good Drug Effect" as measured using a visual analog scale (1-100 mm)
secondary outcomes
Time frame: 7 hours
Subject ratings of "High" as measured using a visual analog scale (1-100 mm)
Time frame: 7 hours
Subject ratings of Painfulness and Bothersomeness of the Cold Pressor Test
Publications
No exact PMID-linked public article is currently readable locally.